Literature DB >> 20881084

NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary.

Elizabeth A Yetley1, Christine M Pfeiffer, Rosemary L Schleicher, Karen W Phinney, David A Lacher, Sylvia Christakos, John H Eckfeldt, James C Fleet, George Howard, Andrew N Hoofnagle, Siu L Hui, Gary L Lensmeyer, Joseph Massaro, Munro Peacock, Bernard Rosner, Donald Wiebe, Regan L Bailey, Paul M Coates, Anne C Looker, Christopher Sempos, Clifford L Johnson, Mary Frances Picciano.   

Abstract

A roundtable to discuss monitoring of serum 25-hydroxyvitamin D [25(OH)D] in the NHANES was held in late July 2009. Topics included the following: 1) options for dealing with assay fluctuations in serum 25(OH)D in the NHANES conducted between 1988 and 2006; 2) approaches for transitioning between the RIA used in the NHANES between 1988 and 2006 to the liquid chromatography tandem MS (LC-MS/MS) measurement procedure to be used in NHANES 2007 and later; 3) approaches for integrating the recently available standard reference material for vitamin D in human serum (SRM 972) from the National Institute of Standards and Technology (NIST) into the NHANES; 4) questions regarding whether the C-3 epimer of 25-hydroxyvitamin D3 [3-epi-25(OH)D3] should be measured in NHANES 2007 and later; and 5) identification of research and educational needs. The roundtable experts agreed that the NHANES data needed to be adjusted to control for assay fluctuations and offered several options for addressing this issue. The experts suggested that the LC-MS/MS measurement procedure developed by NIST could serve as a higher order reference measurement procedure. They noted the need for a commutability study for the recently released NIST SRM 972 across a range of measurement procedures. They suggested that federal agencies and professional organizations work with manufacturers to improve the quality and comparability of measurement procedures across all laboratories. The experts noted the preliminary nature of the evidence of the 3-epi-25(OH)D3 but felt that it should be measured in 2007 NHANES and later.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881084      PMCID: PMC2955879          DOI: 10.3945/jn.110.121483

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  23 in total

1.  C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status.

Authors:  Ravinder J Singh; Robert L Taylor; G Satyanarayana Reddy; Stefan K G Grebe
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

2.  25-Hydroxyvitamin D assays: the quest for accuracy.

Authors:  Graham D Carter
Journal:  Clin Chem       Date:  2009-05-07       Impact factor: 8.327

Review 3.  Assessing the vitamin D status of the US population.

Authors:  Elizabeth A Yetley
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

4.  Data advisory with regard to NHANES serum 25-hydroxyvitamin D data.

Authors:  Anne C Looker; David A Lacher; Christine M Pfeiffer; Rosemary L Schleicher; Mary Frances Picciano; Elizabeth A Yetley
Journal:  Am J Clin Nutr       Date:  2009-07-01       Impact factor: 7.045

Review 5.  Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program.

Authors:  Gary L Myers; W Greg Miller; Josef Coresh; James Fleming; Neil Greenberg; Tom Greene; Thomas Hostetter; Andrew S Levey; Mauro Panteghini; Michael Welch; John H Eckfeldt
Journal:  Clin Chem       Date:  2005-12-06       Impact factor: 8.327

6.  HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays.

Authors:  Gary L Lensmeyer; Donald A Wiebe; Neil Binkley; Marc K Drezner
Journal:  Clin Chem       Date:  2006-03-30       Impact factor: 8.327

7.  Accuracy verification and identification of matrix effects. The College of American Pathologists' Protocol.

Authors:  J H Eckfeldt; K R Copeland
Journal:  Arch Pathol Lab Med       Date:  1993-04       Impact factor: 5.534

8.  Summary of roundtable discussion on vitamin D research needs.

Authors:  Patsy M Brannon; Elizabeth A Yetley; Regan L Bailey; Mary Frances Picciano
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

9.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004.

Authors:  Anne C Looker; Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Mary Frances Picciano; Elizabeth A Yetley
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

10.  Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference.

Authors:  Heinz Jürgen Roth; Heinrich Schmidt-Gayk; Holger Weber; Christoph Niederau
Journal:  Ann Clin Biochem       Date:  2008-03       Impact factor: 2.057

View more
  62 in total

1.  Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006.

Authors:  Amy L Skversky; Juhi Kumar; Matthew K Abramowitz; Frederick J Kaskel; Michal L Melamed
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey.

Authors:  Kurtis Sarafin; Ramón Durazo-Arvizu; Lu Tian; Karen W Phinney; Susan Tai; Johanna E Camara; Joyce Merkel; Evan Green; Christopher T Sempos; Stephen P J Brooks
Journal:  Am J Clin Nutr       Date:  2015-09-30       Impact factor: 7.045

Review 3.  A Review of Cutoffs for Nutritional Biomarkers.

Authors:  Ramkripa Raghavan; Fayrouz Sakr Ashour; Regan Bailey
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

4.  Standardization of measurements of 25-hydroxyvitamin D3 and D2.

Authors:  Linda M Thienpont; Hedwig C M Stepman; Hubert W Vesper
Journal:  Scand J Clin Lab Invest Suppl       Date:  2012

5.  Associations between vitamin D levels and polycystic ovary syndrome phenotypes.

Authors:  Erin M Davis; Jennifer D Peck; Karl R Hansen; Barbara R Neas; LaTasha B Craig
Journal:  Minerva Endocrinol       Date:  2018-04-12       Impact factor: 2.184

6.  National Estimates of Serum Total 25-Hydroxyvitamin D and Metabolite Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry in the US Population during 2007-2010.

Authors:  Rosemary L Schleicher; Maya R Sternberg; Anne C Looker; Elizabeth A Yetley; David A Lacher; Christopher T Sempos; Christine L Taylor; Ramon A Durazo-Arvizu; Khin L Maw; Madhulika Chaudhary-Webb; Clifford L Johnson; Christine M Pfeiffer
Journal:  J Nutr       Date:  2016-04-06       Impact factor: 4.798

7.  Vitamin D and uterine leiomyoma among a sample of US women: Findings from NHANES, 2001-2006.

Authors:  Susanna D Mitro; Ami R Zota
Journal:  Reprod Toxicol       Date:  2015-06-03       Impact factor: 3.143

Review 8.  Challenges and Lessons Learned in Generating and Interpreting NHANES Nutritional Biomarker Data.

Authors:  Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Clifford L Johnson; Elizabeth A Yetley
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

9.  Vitamin D measurement and effect on outcome in a cohort of patients with heart failure.

Authors:  Federica Saponaro; Alessandro Saba; Sabina Frascarelli; Concetta Prontera; Aldo Clerico; Marco Scalese; Maria Rita Sessa; Filomena Cetani; Simona Borsari; Elena Pardi; Antonella Marvelli; Claudio Marcocci; Claudio Passino; Riccardo Zucchi
Journal:  Endocr Connect       Date:  2018-07-26       Impact factor: 3.335

10.  Vitamin D deficiency and electrocardiographic subclinical myocardial injury: Results from National Health and Nutrition Examination Survey-III.

Authors:  Muhammad I Ahmad; Parag A Chevli; Yabing Li; Elsayed Z Soliman
Journal:  Clin Cardiol       Date:  2018-11-20       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.